Sunshine Biopharma Inc. Net Fee Amt
Sunshine Biopharma Inc. (SBFM) had Net Fee Amt of $4.29 thousand as of 2026-08-24, per its S-1 filed 2026-08-28.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-28
- 2026-08-24: Net Fee Amt $4.29K.
- 2026-05-07: Net Fee Amt $2.49K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-24 | $4.29K S-1 · filed 2026-08-28 |
| 2026-05-07 | $2.49K S-1 · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |